Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
1 other identifier
observational
160
0 countries
N/A
Brief Summary
The aim of this study is to determine the prevalence of anxiety and depression among hemodialysis patients attending Sohag University Hospital and to identify the sociodemographic and clinical factors associated with these psychological disorders. The study is a descriptive cross-sectional study conducted on patients undergoing maintenance hemodialysis at the Hemodialysis Unit, Sohag University Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2026
CompletedFirst Posted
Study publicly available on registry
March 31, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
March 31, 2026
February 1, 2026
4 months
February 28, 2026
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Questionnaire for the Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital
From enrollment to the end of treatment at 8 weeks
Study Arms (1)
CKD on dialysis patients
Interventions
Eligibility Criteria
CKD on dialysis patients at Sohag University
You may qualify if:
- Patients diagnosed with end-stage renal disease (ESRD) and maintained on regular hemodialysis for at least 3 months.
- Patients aged more than 18 years old.
- Patients receiving hemodialysis three sessions per week, each lasting 3-4 hours.
- Patients who can communicate effectively and are able to complete the required questionnaires.
- Patients able to provide informed consent.
You may not qualify if:
- Patients suffering from major visual or hearing impairments.
- Patients with a known psychiatric disorder diagnosed prior to initiation of hemodialysis.
- Patients receiving psychiatric medications or active psychotherapy.
- Patients with severe cerebrovascular diseases.
- Patients with chronic liver diseases, lung diseases or malignancies that can add additional psychological burden.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator Norhan Hussien Abd El-Rheem
Study Record Dates
First Submitted
February 28, 2026
First Posted
March 31, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
March 31, 2026
Record last verified: 2026-02